We have shown that in a COPD model, in which Class I and II HDACs are inhibited, Nrf2 protein is further acetylated and its stability is decreased along with its anti-oxidant potential which might contribute to COPD pathogenesis. Here, NFE2L2 is linked to chronic obstructive pulmonary disease.